Role of Some Serum Biomarkers in the Early Detection of Diabetic Cardiomyopathy

References

• LamCS. Diabetic cardiomyopathy: an expression of stage B heart failure with preserved ejection fraction. Diab. Vasc. Dis. Res.12(4), 234–238 (2015).
   PubMed Web of Science ®Google Scholar
• AshourK. Early detection of diastolic dysfunction in diabetic patients (Single Center Cross sectional Study) – J. Heart Cardiovasc. Res.2(1), 114 (2018).
   Google Scholar
• LeeMMY , McMurrayJJV , Lorenzo-AlmorósAet al.Diabetic cardiomyopathy. Heart Heart105(4), 337–345 (2018).
   PubMed Web of Science ®Google Scholar
• LeeWS , KimJ. Diabetic cardiomyopathy: where we are and where we are going. Korean J. Int. Med.32(3), 404–421 (2017).
   PubMed Web of Science ®Google Scholar
• JiaG , HillMA , SowersJR. Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity. Circ. Res.122(4), 624–638 (2018).
   PubMed Web of Science ®Google Scholar
• JiaG , DeMarcoVG , SowersJR. Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy. Nat. Rev. Endocrinol.12(3), 144–153 (2016).
   PubMed Web of Science ®Google Scholar
• BajpaiA , TilleyDG. The role of leukocytes in diabetic cardiomyopathy. Front. Physiol.9(1547), 1–12 (2018).
   PubMedGoogle Scholar
• GandhiPU , GagginHK , SheftelADet al.Prognostic usefulness of insulin-like growth factor-binding protein 7 in heart failure with reduced ejection fraction: a novel biomarker of myocardial diastolic function?Am. J. Cardiol.114(10), 1543–1549 (2014).
   PubMed Web of Science ®Google Scholar
• LangRM , BierigM , DevereuxRBet al.Recommendations for chamber quantification. Eur. J. Echocardiogr.7(2), 79–108 (2006).
   PubMed Web of Science ®Google Scholar
• NaguehSF , SmisethOA , AppletonCPet al.Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J. Am. Soc. Echocardiogr.29(4), 277–314 (2016).
   PubMed Web of Science ®Google Scholar
• SchillerNB , ShahPM , CrawfordMet al.Recommendations for quantification of the left ventricle by 2-dimensional echocardiography. J. Am. Soc. Echocardiogr.2(5), 358–367 (1989).
   PubMedGoogle Scholar
• GoudaM , KhalilWA. The determinants of deleterious effects of diabetes on the myocardium. J. Cardio. Curr. Res.7(1), 00236 (2016).
   Google Scholar
• BorghettiG , von LewinskiD , EatonD , SourijH , HouserS , WallnerM. Diabetic cardiomyopathy: current and future therapies. Beyond glycemic control. Front. Physiol.9, 1514 (2018).
   PubMed Web of Science ®Google Scholar
• HaugenE1 , GanLM , IsicA , SkommevikT , FuM. Increased interleukin-6 but not tumor necrosis factor-alpha predicts mortality in the population of elderly heart failure patients. Exp. Clin. Cardiol.13(1), 19–24 (2008).
   PubMedGoogle Scholar
• Markousis-MavrogenisG , TrompJ , OuwerkerkWet al.The clinical significance of interleukin-6 in heart failure: results from the BIOSTAT-CHF study. Eur. J. Heart Fail.21, 965–973 (2019).
   PubMed Web of Science ®Google Scholar
• ShaverA , NicholsA , ThompsonEet al.Role of serum biomarkers in early detection of diabetic cardiomyopathy in the West Virginian Population. Int. J. Med. Sci.13(3), 161–168 (2016).
   PubMed Web of Science ®Google Scholar
• DinhW , FüthR , NicklWet al.Elevated plasma levels of TNF-alpha and Interleukin-6 in patients with diastolic dysfunction and glucose metabolism disorders. Cardiovasc. Diabetol.8, 58 (2009).
   PubMed Web of Science ®Google Scholar
• GullestadL , UelandT , VingeE , FinsenA , YndestadA , AukrustP. Inflammatory cytokines in heart failure: mediators and markers. Cardiology122, 23–35 (2012).
   PubMed Web of Science ®Google Scholar
• EskandariV , AmirzargarAA , MahmoudiMJ. Gene expression and levels of IL-6 and TNFα in PBMCs correlate with severity and functional class in patients with chronic heart failure. Ir. J. Med. Sci.187(2), 359–368 (2018).
   PubMed Web of Science ®Google Scholar
• HaugenE , ChenJ , WikstromJ , GronrosJ , GanLM , FuLX. Parallel gene expressions of IL-6 and BNP during cardiac hypertrophy complicated with diastolic dysfunction in spontaneously hypertensive rats. Int. J. Cardiol.115(1), 24–28 (2007).
   PubMed Web of Science ®Google Scholar
• LiuQ , WangS , CaiL. Diabetic cardiomyopathy and its mechanisms: role of oxidative stress and damage. J. Diabetes Investig.5(6), 623–634 (2014).
   PubMed Web of Science ®Google Scholar
• MishraPK , YingW , NandiSS , BandyopadhyayGK , PatelKK , MahataSK. Diabetic cardiomyopathy: an immunometabolic perspective. Front. Endocrinol.8(72), 1–12 (2017).
   PubMedGoogle Scholar
• YamagishiS , NakamuraN , SuematsuM , KasedaK , MatsuiT. Advanced glycation end products: a molecular target for vascular complications in diabetes. Mol. Med.21(Suppl. 1), S32–S40 (2015).
   PubMed Web of Science ®Google Scholar
• GawlowskiT , StratmannB , StorkIet al.Heat shock protein 27 modification is increased in the human diabetic failing heart. Horm. Metab. Res.41(8), 594–599 (2009).
   PubMed Web of Science ®Google Scholar
• PetrovaR , YamamotoY , MurakiKet al.Advanced glycation end product-induced calcium handling impairment in mouse cardiac myocytes. J. Mol. Cell. Cardiol.34(10), 1425–1431 (2002).
   PubMed Web of Science ®Google Scholar
• BuggerH , AbelED. Molecular mechanisms of diabetic cardiomyopathy. Diabetologia57(4), 660–671 (2014).
   PubMed Web of Science ®Google Scholar
• YilmazS , CanpolatU , AydogduS , AbboudHE. Diabetic cardiomyopathy; summary of 41 years. Korean Circ. J.45(4), 266–272 (2015).
   PubMed Web of Science ®Google Scholar
• GuidoMC , MarquesAF , TavaresER , Tavaresde Melo MD , SalemiV , MaranhãoRC. The effects of diabetes induction on the rat heart: differences in oxidative stress, inflammatory cells, and fibrosis between sub-endocardial and interstitial myocardial areas. Oxid. Med. Cell Longev.2017(1), 1–11 (2017).
   Google Scholar
• LinssenP , HenryR , SchalkwijkCet al.Serum advanced glycation end-products are associated with left ventricular dysfunction in normal glucose metabolism but not in Type 2 diabetes: the Hoorn Study. Diab. Vasc. Dis. Res.13(4), 278–285 (2016).
   PubMed Web of Science ®Google Scholar
• RuanW , LaiM. Insulin-like growth factor binding protein: a possible marker for the metabolic syndrome?Acta Diabetol.47(1), 5–14 (2010).
   PubMed Web of Science ®Google Scholar
• ChughS , OuzounianM , LuZet al.Pilot study identifying myosin heavy chain 7, desmin, insulin-like growth factor 7, and annexin A2 as circulating biomarkers of human heart failure. Proteomics13(15), 2324–2334 (2013).
   PubMed Web of Science ®Google Scholar
• GuoH , LiuX , ZhangYet al.Insulin-like growth factor binding protein-related protein 1 contributes to hepatic fibrogenesis. J. Dig. Dis.15(4), 202–210 (2014).
   PubMed Web of Science ®Google Scholar
• BakhoumSWG , SorourSM , ElramlyMZ , RaslanHZ , SalamaII. Impact of waist circumference on hospital outcome and coronary angiographic findings of patients with acute ST-segment elevation myocardial infarction. Egyptian Heart J.67(2), 159–165 (2015).
   Google Scholar
• StrattonIM , AdlerAI , NeilHAet al.Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ321(7258), 405–412 (2000).
   PubMed Web of Science ®Google Scholar
• PerumalV , NarayananN , RangarajanJet al.A study to correlate HBA1c levels and left ventricular diastolic dysfunction in newly diagnosed Type II diabetes mellitus. J. Evolution Med. Dent. Sci.5(51), 3312–3317 (2016).
   Google Scholar
• MuhammadZ , HashmiA. Frequency of diabetic cardiomyopathy among Type-2 diabetics presenting as heart failure. J. Coll. Physicians Surg. Pak.23(8), 538–542 (2013).
   PubMed Web of Science ®Google Scholar
• Lorenzo-AlmorósA , Cepeda-RodrigoJM , LorenzoÓ. Diabetic cardiomyopathy. Rev. Clin. Esp.S0014-2565(20), 30025–4 (2020).
   Google Scholar